Table 4. Results of univariate and multivariate analyses to examine clinical parameters associated with occipital, parietal and frontal PK11195 Binding Potential (BP).

Cerebral locationof PK11195binding Potential (BP)	Occipital	Occipital	Parietal	Parietal	Frontal	Frontal
	Univariate	Multivariate	Univariate	Multivariate	Univariate	Multivariate
Clinical parameter	p -value [95% CI]	p- value [95% CI]	p -value [95% CI]	p- value [95% CI]	p -value [95% CI]	p- value [95% CI]
aHCV study group	0.10 [−0.15, 0.01]	0.11 [−0.13, 0.02]	0.33 [−0.10, 0.03]	−	0.26 [−0.58, 0.17]	−
Nadir CD4+ count,per 100 cell/uL increase	0.65 [−0.02, 0.03]	−	0.18 [−0.01, 0.03]	−	0.24 [−0.04, 0.14]	−
Current CD4+ count,per 100 cell/uL increase	0.68 [−0.02, 0.03]	−	0.06 [−0.01, 0.03]	0.14 [−0.01, 0.02]	0.13 [−0.02, 0.17]	0.29 [−0.04, 0.14]
Age, per 10 year increase	0.62 [−0.05, 0.03]	−	0.48 [−0.04, 0.02]	−	0.35 [−0.87, −0.07]	−
Receiving cART	0.06 [−0.19, 0.00]	0.07 [−0.18, 0.09]	0.01 [−0.15, −0.02]	0.03 [−0.14, −0.01]	0.03 [−0.87, −0.07]	0.05 [−0.82, 0.02]